» Articles » PMID: 29058068

Clinical Outcomes of Gastric Cancer Patients Who Underwent Proximal or Total Gastrectomy: A Propensity Score-Matched Analysis

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2017 Oct 24
PMID 29058068
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Total gastrectomy (TG) and proximal gastrectomy (PG) are used to treat upper-third early gastric cancer. To date, no consensus has been reached regarding which procedure should be selected. The aim of this study was to validate the usefulness of preserving the stomach in early upper-third gastric cancer.

Methods: Between 2004 and 2013, 201 patients underwent PG or TG at our institution for treatment of upper-third early gastric cancer. According to the defined inclusion and exclusion criteria, 192 cases were enrolled in this study. One-to-one propensity score matching was performed to compare the outcomes between the two groups.

Results: The operation time was shorter in the PG group. Although no significant difference was observed, the PG group had less bleeding and fewer postoperative complications. R0 resection rate was 100%, and no surgery-related deaths were observed. The frequencies of reflux symptoms and anastomotic stenosis were significantly higher in the PG group, but could be controlled by balloon dilation and drug therapy. The maintenance rates of body mass index and lean body mass were significantly higher in patients who underwent PG than TG. The total protein and serum albumin values were higher in the PG group than in the TG group and remained statistically superior.

Conclusion: PG group exhibited better perioperative performance. Furthermore, better nutritional results were obtained in the PG group. Although the late stenosis and reflux symptoms must be addressed, the PG is a preferable surgical procedure for the treatment of early proximal gastric cancer.

Citing Articles

Comparing survival after proximal gastrectomy vs. total gastrectomy in advanced gastric cancer: A systematic review and meta‑analysis.

Su P, Huang Y, Liao T, Lu W, Wang C, Chao Y Oncol Lett. 2024; 28(3):427.

PMID: 39021734 PMC: 11253084. DOI: 10.3892/ol.2024.14560.


Study of Short-Term and Long-Term Outcomes Between Esophagogastrostomy and Double-Tract Reconstruction After Proximal Gastrectomy.

Hasegawa T, Kubo N, Sakurai K, Nishimura J, Iseki Y, Nishii T J Gastrointest Cancer. 2024; 55(3):1089-1097.

PMID: 38607505 DOI: 10.1007/s12029-024-01050-6.


Effect of Vitamin B12 Replacement Intervals on Clinical Symptoms and Laboratory Findings in Gastric Cancer Patients after Total Gastrectomy.

Park S, Eom S, Lee H, Eom B, Yoon H, Kim Y Cancers (Basel). 2023; 15(20).

PMID: 37894305 PMC: 10605534. DOI: 10.3390/cancers15204938.


Outcomes of Proximal Versus Total Gastrectomy for Proximal Gastric Cancer: A Propensity Score-Matched Analysis of a Western Center Experience.

Uprak T, Ergenc M, Akmercan A, Yegen C J Gastrointest Surg. 2023; 27(8):1560-1567.

PMID: 37130980 DOI: 10.1007/s11605-023-05686-w.


Advantages of Function-Preserving Gastrectomy for Older Patients With Upper-Third Early Gastric Cancer: Maintenance of Nutritional Status and Favorable Survival.

Terayama M, Ohashi M, Ida S, Hayami M, Makuuchi R, Kumagai K J Gastric Cancer. 2023; 23(2):303-314.

PMID: 37129154 PMC: 10154138. DOI: 10.5230/jgc.2023.23.e9.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Wu H, Rusiecki J, Zhu K, Potter J, Devesa S . Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009; 18(7):1945-52. PMC: 2786772. DOI: 10.1158/1055-9965.EPI-09-0250. View

3.
VISICK A . Measured radical gastrectomy; review of 505 operations for peptic ulcer. Lancet. 1948; 1(6502):551-5. View

4.
Dassen A, Lemmens V, van de Poll-Franse L, Creemers G, Brenninkmeijer S, Lips D . Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer. 2010; 46(6):1101-10. DOI: 10.1016/j.ejca.2010.02.013. View

5.
Steevens J, Botterweck A, Dirx M, van den Brandt P, Schouten L . Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2009; 22(6):669-78. DOI: 10.1097/MEG.0b013e32832ca091. View